Ymmunobio
Biotechnology, 85 Broad St, Basel, New York, 10004, United States, 1-10 Employees
Phone Number: +17*********
Who is YMMUNOBIO
Ymmunobio is a preclinical stage oncology biotech company focused on the development of innovative treatments for cancer patients through new classes of antibodies. Those treatments prese...
Read More
-
Headquarters: 85 Broad St, Basel, New York, 10004, United States
-
Date Founded: 2021
-
Employees: 1-10
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Ymmunobio
Answer: Ymmunobio's headquarters are located at 85 Broad St, Basel, New York, 10004, United States
Answer: Ymmunobio's phone number is +17*********
Answer: Ymmunobio's official website is https://ymmunobio.com
Answer: Ymmunobio's revenue is $10 Million to $25 Million
Answer: Ymmunobio's SIC: 2836
Answer: Ymmunobio's NAICS: 541714
Answer: Ymmunobio has 1-10 employees
Answer: Ymmunobio is in Biotechnology
Answer: Ymmunobio contact info: Phone number: +17********* Website: https://ymmunobio.com
Answer: Ymmunobio is a preclinical stage oncology biotech company focused on the development of innovative treatments for cancer patients through new classes of antibodies. Those treatments present a large market potential and broad applicability in solid tumors. Ymmunobio is making extensive progress in developing antibodies that have an influence on the immune system by reinstating its immune response to cancers or directly inhibiting cancer cell proliferation.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month